for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Hester Biosciences Ltd

HEST.NS

Latest Trade

1,730.90INR

Change

15.65(+0.91%)

Volume

1,794

Today's Range

1,695.10

 - 

1,740.00

52 Week Range

1,033.50

 - 

2,048.00

As of on the National Stock Exchange of India ∙ Minimum 15 minute delay

Pricing

Previous Close
1,715.25
Open
1,733.95
Volume
1,794
3M AVG Volume
0.13
Today's High
1,740.00
Today's Low
1,695.10
52 Week High
2,048.00
52 Week Low
1,033.50
Shares Out (MIL)
8.51
Market Cap (MIL)
14,460.82
Forward P/E
27.45
Dividend (Yield %)
0.65

Next Event

Hester Biosciences Ltd Annual Shareholders Meeting

Latest Developments

More

Hester Biosciences CFO Jigar Shah Resigns

India's Hester Biosciences March-Qtr Profit Rises

India's Hester Biosciences Dec-Qtr Profit Rises

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Hester Biosciences Ltd

Hester Biosciences Limited is an India-based company engaged in manufacturing of poultry vaccines and large animal vaccines, and trading of poultry health products and large animal health products. Its segments include Poultry Division and Large Animal Division. It provides over 40 products across poultry vaccines (live and inactivated), large animal vaccines (live and inactivated), health products and diagnostics. Its product range includes vaccines, drugs, feed supplements and disinfectants. It manufactures over two live vaccines for large animals, including Peste des Petits Ruminants (PPR) Live vaccines and Goat Pox Vaccine. Its offerings include Avian, including Live B1, Live LAS, Live R2B, Live M48, Live FP, Gumboro M1, Gumboro I and Gumboro I+; swine fever vaccines, and large animal, including PPR Vaccine-Sungri 96 strain and Brucella abortus (S19) calf Vaccine. It offers services, such as seromonitoring for poultry farms and mastitis prevention programs for cattle farms.

Industry

Biotechnology & Drugs

Contact Info

16/10,DEVENDRA SOCIETY

NR NARANPURA POST OFFICE, NARANPURA

+91.79.26445107

https://www.hester.in/

Executive Leadership

Bhupendra V. Gandhi

Non-Independent Non-Executive Chairman of the Board

Rajiv D. Gandhi

Chief Executive Officer, Managing Director, Non-Independent Executive Director

Jigar Shah

Chief Financial Officer

Vinod Mali

Compliance Officer, Company Secretary

Ravin Gandhi

Non-Executive Non-Independent Director

Key Stats

2.00 mean rating - 1 analysts
Sell
Hold
Buy
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

BRIEF-India's Hester Biosciences Dec-Qtr Profit Rises

* DEC QUARTER PROFIT 65 MILLION RUPEES VERSUS PROFIT 58.2 MILLION RUPEES YEAR AGO

BRIEF-India's Hester Biosciences Sept-qtr profit rises

* Sept quarter profit 88.6 million rupees versus profit of 59.9 million rupees year ago

BRIEF-India's Hester Biosciences June-qtr profit rises

* June quarter profit 61.8 million rupees versus profit 60.2 million rupees year ago

BRIEF-India's Hester Biosciences approves investment of $3 mln in African unit

* Says board approval for investing USD 3 million in wholly owned African subsidiary

BRIEF-Hester Biosciences approves to make investment in Hester Biosciences Africa

* Says approved to make investment in unit Hester Biosciences Africa Ltd to the extent of $3 million Source text - (http://bit.ly/2sC8xN7) Further company coverage:

BRIEF-India's Hester Biosciences March-qtr profit rises

* March quarter net profit 70.8 million rupees versus profit 55.1 million rupees year ago

BRIEF-Hester Biosciences to invest in Texas Laboratories, Gujarat

* Says decided to make investment in the partnership firm namely, Texas Laboratories, Mehsana, Gujarat

BRIEF-Hester biosciences to consider proposed investments in existing partnership firm

* Says to consider proposed investments in an existing partnership firm Source text: http://bit.ly/2mWldgS Further company coverage:

BRIEF-Hester Biosciences Dec qtr profit rises

* Hester Biosciences Ltd - dec quarter net profit 58 million rupees versus profit 47.6 million rupees year ago

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up